Published in Exp Mol Med on October 31, 2011
TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice. Gut (2015) 0.89
Circadian regulation of low density lipoprotein receptor promoter activity by CLOCK/BMAL1, Hes1 and Hes6. Exp Mol Med (2012) 0.85
Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice. Toxicol Appl Pharmacol (2013) 0.83
Soaping up type 2 diabetes with bile acids?: the link between glucose and bile acid metabolism in humans tightens: quality matters! Diabetes (2013) 0.75
Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature (2003) 9.77
Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1. Proc Natl Acad Sci U S A (1999) 7.70
A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol Cell (2000) 7.18
Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol Cell (2000) 6.48
Negative regulation of the forkhead transcription factor FKHR by Akt. J Biol Chem (1999) 5.66
Stressing the role of FoxO proteins in lifespan and disease. Nat Rev Mol Cell Biol (2007) 4.73
FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab (2005) 3.47
FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem (2006) 3.35
Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J Biol Chem (2004) 2.73
Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated Type I (slow twitch/red muscle) fiber genes, and impaired glycemic control. J Biol Chem (2004) 2.72
Role of hypothalamic Foxo1 in the regulation of food intake and energy homeostasis. Nat Neurosci (2006) 2.36
Foxo1 mediates insulin action on apoC-III and triglyceride metabolism. J Clin Invest (2004) 1.93
Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1. J Biol Chem (2004) 1.90
Cloning and regulation of cholesterol 7 alpha-hydroxylase, the rate-limiting enzyme in bile acid biosynthesis. J Biol Chem (1990) 1.79
Cholesterol 7 alpha-hydroxylase. J Lipid Res (1977) 1.69
PGC-1alpha activates CYP7A1 and bile acid biosynthesis. J Biol Chem (2003) 1.49
Differential regulation of rat and human CYP7A1 by the nuclear oxysterol receptor liver X receptor-alpha. Mol Endocrinol (2002) 1.25
Characterization of hepatic-specific regulatory elements in the promoter region of the human cholesterol 7alpha-hydroxylase gene. J Biol Chem (1997) 1.23
Role of FoxO Proteins in Pancreatic beta Cells. Endocr J (2007) 1.23
FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action. J Biol Chem (2009) 1.19
Insulin regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c. J Biol Chem (2006) 1.17
Role of FXR and FTF in bile acid-mediated suppression of cholesterol 7alpha-hydroxylase transcription. Nucleic Acids Res (2000) 1.15
Insulin suppresses bile acid synthesis in cultured rat hepatocytes by down-regulation of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase gene transcription. Hepatology (1995) 1.10
Functional interaction of hepatic nuclear factor-4 and peroxisome proliferator-activated receptor-gamma coactivator 1alpha in CYP7A1 regulation is inhibited by a key lipogenic activator, sterol regulatory element-binding protein-1c. Mol Endocrinol (2007) 1.04
Mice expressing the human CYP7A1 gene in the mouse CYP7A1 knock-out background lack induction of CYP7A1 expression by cholesterol feeding and have increased hypercholesterolemia when fed a high fat diet. J Biol Chem (2002) 0.98
Nuclear receptor-mediated repression of human cholesterol 7alpha-hydroxylase gene transcription by bile acids. J Lipid Res (2001) 0.94
Forkhead box transcription factor O1 inhibits cholesterol 7alpha-hydroxylase in human hepatocytes and in high fat diet-fed mice. Biochim Biophys Acta (2009) 0.94
Sterol-independent repression of low density lipoprotein receptor promoter by peroxisome proliferator activated receptor gamma coactivator-1alpha (PGC-1alpha). Exp Mol Med (2009) 0.89
Differential regulation of human and mouse orphan nuclear receptor small heterodimer partner promoter by sterol regulatory element binding protein-1. J Biol Chem (2004) 0.88
The forkhead transcription factor Foxo1: a possible link between obesity and insulin resistance. Mol Cell (2003) 0.86
The coming of age of our understanding of the enterohepatic circulation of bile salts. Am J Surg (2003) 0.84
Orphan nuclear receptor small heterodimer partner inhibits angiotensin II- stimulated PAI-1 expression in vascular smooth muscle cells. Exp Mol Med (2010) 0.79
Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells. Biochem Biophys Res Commun (2006) 2.15
C1q tumor necrosis factor alpha-related protein isoform 5 is increased in mitochondrial DNA-depleted myocytes and activates AMP-activated protein kinase. J Biol Chem (2009) 1.38
Chronic exposure to the herbicide, atrazine, causes mitochondrial dysfunction and insulin resistance. PLoS One (2009) 1.27
The mitogenic and antiapoptotic actions of ghrelin in 3T3-L1 adipocytes. Mol Endocrinol (2004) 1.20
Brain-type creatine kinase has a crucial role in osteoclast-mediated bone resorption. Nat Med (2008) 1.16
Fetal and early postnatal protein malnutrition cause long-term changes in rat liver and muscle mitochondria. J Nutr (2003) 1.04
Negative cross-talk between Nur77 and small heterodimer partner and its role in apoptotic cell death of hepatoma cells. Mol Endocrinol (2004) 1.00
HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo. Circulation (2005) 0.98
Overexpression of TFAM, NRF-1 and myr-AKT protects the MPP(+)-induced mitochondrial dysfunctions in neuronal cells. Biochim Biophys Acta (2011) 0.96
Meal time shift disturbs circadian rhythmicity along with metabolic and behavioral alterations in mice. PLoS One (2012) 0.94
Novel cell-based assay reveals associations of circulating serum AhR-ligands with metabolic syndrome and mitochondrial dysfunction. Biofactors (2013) 0.94
Resistance of mitochondrial DNA-deficient cells to TRAIL: role of Bax in TRAIL-induced apoptosis. Oncogene (2002) 0.93
Cellular aging of mitochondrial DNA-depleted cells. Biochem Biophys Res Commun (2004) 0.90
In vitro methylation of nuclear respiratory factor-1 binding site suppresses the promoter activity of mitochondrial transcription factor A. Biochem Biophys Res Commun (2004) 0.90
Sterol-independent repression of low density lipoprotein receptor promoter by peroxisome proliferator activated receptor gamma coactivator-1alpha (PGC-1alpha). Exp Mol Med (2009) 0.89
Inhibition of inflammation and oxidative stress by Angelica dahuricae radix extract decreases apoptotic cell death and improves functional recovery after spinal cord injury. J Neurosci Res (2011) 0.89
Regulation of insulin secretion and beta-cell mass by activating signal cointegrator 2. Mol Cell Biol (2006) 0.88
Mitochondria-based model for fetal origin of adult disease and insulin resistance. Ann N Y Acad Sci (2005) 0.87
Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha) on mitochondrial transcription factor A (Tfam) promoter. Biochem Biophys Res Commun (2006) 0.86
Uppsala Consensus Statement on Environmental Contaminants and the Global Obesity Epidemic. Environ Health Perspect (2016) 0.86
Circadian regulation of low density lipoprotein receptor promoter activity by CLOCK/BMAL1, Hes1 and Hes6. Exp Mol Med (2012) 0.85
Analysis of proteome bound to D-loop region of mitochondrial DNA by DNA-linked affinity chromatography and reverse-phase liquid chromatography/tandem mass spectrometry. Ann N Y Acad Sci (2005) 0.84
The role of mitochondrial DNA in the development of type 2 diabetes caused by fetal malnutrition. J Nutr Biochem (2005) 0.84
Characterization of the 5'-flanking region of the rat gene for mitochondrial transcription factor A (Tfam). Biochim Biophys Acta (2002) 0.84
Umbilical cord mesenchymal stromal cells affected by gestational diabetes mellitus display premature aging and mitochondrial dysfunction. Stem Cells Dev (2015) 0.82
Characterization of mitochondria isolated from normal and ischemic hearts in rats utilizing atomic force microscopy. Micron (2010) 0.81
Regulation of mitochondrial transcription factor A expression by high glucose. Ann N Y Acad Sci (2004) 0.81
S-adenosyl-L-methionine increases skeletal muscle mitochondrial DNA density and whole body insulin sensitivity in OLETF rats. J Nutr (2007) 0.81
Oleic acid induces endothelin-1 expression through activation of protein kinase C and NF-kappa B. Biochem Biophys Res Commun (2003) 0.80
Mitochondrial dysfunction enhances the migration of vascular smooth muscles cells via suppression of Akt phosphorylation. Biochim Biophys Acta (2009) 0.80
Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals (2012) 0.79
Gene expression in uremic left ventricular hypertrophy: effects of hypertension and anemia. Exp Mol Med (2004) 0.79
Aptamer-based immunosensor on the ZnO nanorods networks. J Nanosci Nanotechnol (2012) 0.78
Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications. Exp Mol Med (2002) 0.78
DNA delivery to the mitochondria sites using mitochondrial leader peptide conjugated polyethylenimine. J Drug Target (2007) 0.77
Network clustering revealed the systemic alterations of mitochondrial protein expression. PLoS Comput Biol (2011) 0.77
Inhibition of low density lipoprotein receptor expression by long-term exposure to phorbol ester via p38 mitogen-activated protein kinase pathway. J Cell Biochem (2005) 0.77
Inhibition of lipopolysaccharide-induced inducible nitric oxide synthase expression by a novel compound, mercaptopyrazine, through suppression of nuclear factor-kappaB binding to DNA. Biochem Pharmacol (2004) 0.77
Causal effects of synthetic chemicals on mitochondrial deficits and diabetes pandemic. Arch Pharm Res (2013) 0.76
Induction of hepatic inducible nitric oxide synthase by cholesterol in vivo and in vitro. Exp Mol Med (2002) 0.76
The role of glutamate release on voltage-dependent anion channels (VDAC)-mediated apoptosis in an eleven vessel occlusion model in rats. PLoS One (2010) 0.76
Growth impairment of primary chondrocyte cells by serum of rats with chronic renal failure. Exp Mol Med (2004) 0.76
Serum aryl hydrocarbon receptor ligand activity is associated with insulin resistance and resulting type 2 diabetes. Acta Diabetol (2014) 0.75
Immunosensor based on the ZnO nanorod networks for the detection of H1N1 swine influenza virus. J Nanosci Nanotechnol (2012) 0.75
Quantitative and qualitative analysis of heart mitochondria for evaluating the degree of myocardial injury utilizing atomic force microscopy. Micron (2012) 0.75
Design and synthesis of novel antidiabetic agents. Arch Pharm Res (2005) 0.75
Preparation and application of graphene-poly (diallyldimethylammoniumchloride)-iron oxide nanoparticles buckypaper for hydrogen peroxide detection. J Nanosci Nanotechnol (2013) 0.75
Organelle stress-induced activating transcription factor-3 downregulates low-density lipoprotein receptor expression in Sk-Hep1 human liver cells. Biol Chem (2011) 0.75
Dual-mode enhancement of metallothionein protein with cell transduction and retention peptide fusion. J Control Release (2013) 0.75